BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31541928)

  • 1. Construction of a comprehensive nutritional index and its correlation with quality of life and survival in patients with nasopharyngeal carcinoma undergoing IMRT: A prospective study.
    Deng J; He Y; Sun XS; Li JM; Xin MZ; Li WQ; Li ZX; Nie S; Wang C; Li YZ; Chen LP; Chen LM; Zhu SH; Li JW; Hu W; Fan YY; Guo SS; Mai HQ
    Oral Oncol; 2019 Nov; 98():62-68. PubMed ID: 31541928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between the Comprehensive Nutritional Index and the EORTC QLQ-H&N35 in Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy.
    He Y; Chen L; Chen L; Hu W; Wang C; Tang L; Mai H; Li J; Wu L; Fan Y
    Nutr Cancer; 2017 Apr; 69(3):436-443. PubMed ID: 28287323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between the comprehensive nutrition index and quality of life of patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.
    Ma L; Wu T; Pan J; Kong X; Guo Q; Yang L; Zhang Y; Lin S; Chen C; Huang C
    Nutr Cancer; 2014; 66(1):152-8. PubMed ID: 24328938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective study.
    Duan YY; Deng J; Su DF; Li WQ; Han Y; Li ZX; Huan XZ; Zhu SH; Yang QL; Hu W; Xin MZ; Tang LQ; Mai HQ; Fan YY; He Y
    Support Care Cancer; 2021 Sep; 29(9):5371-5381. PubMed ID: 33686519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
    Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy.
    Huang TL; Tsai MH; Chuang HC; Chien CY; Lin YT; Tsai WL; Fang FM
    Radiat Oncol; 2020 Apr; 15(1):84. PubMed ID: 32307024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified-Nutrition Index is a Significant Prognostic Factor for the Overall Survival of the Nasopharyngeal Carcinoma Patients who Undergo Intensity-modulated Radiotherapy.
    Hong JS; Hua YJ; Su L; Zhang HR; Lv WL; Chen XY; Tian J; Zhang WJ
    Nutr Cancer; 2017 Oct; 69(7):1011-1018. PubMed ID: 28937797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
    Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
    Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma.
    Liu YP; Lv X; Zou X; Hua YJ; You R; Yang Q; Xia L; Guo SY; Hu W; Zhang MX; Chen SY; Lin M; Xie YL; Liu LZ; Sun R; Huang PY; Fan W; Guo X; Hong MH; Chen MY
    Cancer Commun (Lond); 2019 Nov; 39(1):75. PubMed ID: 31730020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.
    Miao J; Xiao W; Wang L; Han F; Wu H; Deng X; Guo X; Zhao C
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1263-1273. PubMed ID: 28247035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiotherapy provides better quality of life than two-dimensional conventional radiotherapy for patients with stage II nasopharyngeal carcinoma.
    Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
    Oncotarget; 2017 Jul; 8(28):46211-46218. PubMed ID: 28515352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasion.
    Liao S; Xie Y; Feng Y; Zhou Y; Pan Y; Fan J; Mi J; Qin X; Yao D; Jiang W
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):429-439. PubMed ID: 31677113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Wei Z; Zhang Z; Luo J; Li N; Peng X
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late toxicity, evolving radiotherapy techniques, and quality of life in nasopharyngeal carcinoma.
    Lastrucci L; Bertocci S; Bini V; Borghesi S; De Majo R; Rampini A; Pernici P; Gennari PG
    Radiol Med; 2017 Apr; 122(4):303-308. PubMed ID: 28070838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of nutritional impairment on treatment-related toxicity and survival in patients with nasopharyngeal carcinoma taking normal nutrition before radiotherapy.
    Su L; Lin Q; Li R; Hua Y; Zhang H; Song X; Ye J; Zhang W; Hong J
    Head Neck; 2020 Dec; 42(12):3580-3589. PubMed ID: 32851765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does MRI-detected cranial nerve involvement affect the prognosis of locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy?
    Zong J; Lin S; Chen Y; Wang B; Xiao Y; Lin J; Li R; Pan J
    PLoS One; 2014; 9(6):e100571. PubMed ID: 24963626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study.
    Liu F; Luo T; Jin T; Zhang J; Xiang Z; Yan R; Xie L; Wu X; Zhang H; Wang F; Li P; Liu L
    BMC Cancer; 2019 Jun; 19(1):554. PubMed ID: 31176358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era.
    Jin YN; Zhang WJ; Cai XY; Li MS; Lawrence WR; Wang SY; Mai DM; Du YY; Luo DH; Mo HY
    Cancer Res Treat; 2019 Jan; 51(1):34-42. PubMed ID: 29409313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
    Yao JJ; Zhang F; Gao TS; Zhang WJ; Lawrence WR; Zhu BT; Zhou GQ; Ma J; Wang SY; Sun Y
    Radiother Oncol; 2019 Mar; 132():178-187. PubMed ID: 30448002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.